Best Biotech Stocks To Buy Under $10 (2026)

While reporting a net loss in mid-2025, it reaffirmed revenue growth guidance of 15–22%. : Trading around $8.05 as of April 2026.

: Highlighted for strengthening its global reach through strategic deals, such as the one with Kyowa Kirin.

Identified as a top pick for its focus on like Fabry and Pompe disease. best biotech stocks to buy under $10

It maintains significant institutional interest, with roughly 31 hedge fund holders reported. :

: Biotech stocks, particularly those under $10, are highly volatile and carry significant risk due to the clinical trial process. Experts like Warren Buffett often avoid the sector because there is no way to fully de-risk clinical trial outcomes. While reporting a net loss in mid-2025, it

Recent Phase 1b study results for its Crohn's disease treatment showed a favorable safety profile with no serious adverse events. :

: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval. Identified as a top pick for its focus

The primary catalyst is upcoming clinical data for ulcerative colitis, expected in the second half of 2027.